{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T01:37:06Z","timestamp":1784943426574,"version":"3.55.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T00:00:00Z","timestamp":1478649600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008018","name":"Victorian Cancer Agency","doi-asserted-by":"publisher","award":["Translational Research Program"],"award-info":[{"award-number":["Translational Research Program"]}],"id":[{"id":"10.13039\/100008018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s11136-016-1443-y","type":"journal-article","created":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T14:21:35Z","timestamp":1478701295000},"page":"1163-1176","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Condition-specific or generic preference-based measures in oncology? A comparison of the EORTC-8D and the EQ-5D-3L"],"prefix":"10.1007","volume":"26","author":[{"name":"Cancer 2015 investigators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8990-9514","authenticated-orcid":false,"given":"Paula K.","family":"Lorgelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Doble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Rowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Brazier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,9]]},"reference":[{"issue":"4","key":"1443_CR1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40273-014-0136-z","volume":"32","author":"T Wisl\u00f8ff","year":"2014","unstructured":"Wisl\u00f8ff, T., Hagen, G., Hamidi, V., Movik, E., Klemp, M., & Olsen, J. A. (2014). Estimating QALY gains in applied studies: A review of cost-utility analyses published in 2010. Pharmacoeconomics, 32(4), 367\u2013375.","journal-title":"Pharmacoeconomics"},{"key":"1443_CR2","unstructured":"National Institute for Health Care and Excellence. (2013). Guide to the methods of technology appraisal. Retrieved November 30, 2015, from http:\/\/publications.nice.org.uk\/guide-to-the-methods-of-technology-appraisal-2013-pmg9\/foreword ."},{"issue":"4","key":"1443_CR3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/hec.4730040402","volume":"4","author":"J Brazier","year":"1995","unstructured":"Brazier, J., & Dixon, S. (1995). The use of condition specific outcome measures in economic appraisal. Health Economics, 4(4), 255\u2013264.","journal-title":"Health Economics"},{"issue":"4","key":"1443_CR4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1023\/A:1023453405252","volume":"12","author":"EA Stolk","year":"2003","unstructured":"Stolk, E. A., & Busschbach, J. J. (2003). Validity and feasibility of the use of condition-specific outcome measures in economic evaluation. Quality of Life Research, 12(4), 363\u2013371.","journal-title":"Quality of Life Research"},{"issue":"3","key":"1443_CR5","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jval.2011.12.003","volume":"15","author":"MM Versteegh","year":"2012","unstructured":"Versteegh, M. M., Leunis, A., Uyl-de Groot, C. A., & Stolk, E. A. (2012). Condition-specific preference-based measures: Benefit or burden? Value in Health, 15(3), 504\u2013513.","journal-title":"Value in Health"},{"issue":"1","key":"1443_CR6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/jnnp.69.1.67","volume":"69","author":"A Schrag","year":"2000","unstructured":"Schrag, A., Selai, C., Jahanshahi, M., & Quinn, N. P. (2000). The EQ-5D: A generic quality of life measure\u2014is a useful instrument to measure quality of life in patients with Parkinson\u2019s disease. Journal of Neurology, Neurosurgery and Psychiatry, 69(1), 67\u201373.","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"5","key":"1443_CR7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1586\/14737167.8.5.453","volume":"8","author":"J Petrillo","year":"2008","unstructured":"Petrillo, J., & Cairns, J. (2008). Converting condition-specific measures into preference-based outcomes for use in economic evaluation. Expert Review of Pharmacoeconomics & Outcomes Research, 8(5), 453\u2013461.","journal-title":"Expert Review of Pharmacoeconomics & Outcomes Research"},{"issue":"2","key":"1443_CR8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10198-009-0168-z","volume":"11","author":"JE Brazier","year":"2010","unstructured":"Brazier, J. E., Yang, Y., Tsuchiya, A., & Rowen, D. L. (2010). A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. European Journal of Health Economics, 11(2), 215\u2013225.","journal-title":"European Journal of Health Economics"},{"issue":"4","key":"1443_CR9","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s11136-015-1116-2","volume":"25","author":"B Doble","year":"2016","unstructured":"Doble, B., & Lorgelly, P. (2016). Mapping the EORTC QLQ-C30 onto the EQ-5D-3L: Assessing the external validity of existing mapping algorithms. Quality of Life Research, 25(4), 891\u2013911.","journal-title":"Quality of Life Research"},{"issue":"1","key":"1443_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7525-12-89","volume":"12","author":"JF Guest","year":"2014","unstructured":"Guest, J. F., Nanuwa, K., & Barden, R. (2014). Utility values for specific hepatic encephalopathy health states elicited from the general public in the United Kingdom. Health and Quality of Life Outcomes, 12(1), 1\u20139.","journal-title":"Health and Quality of Life Outcomes"},{"issue":"7","key":"1443_CR11","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0161-6420(03)00462-7","volume":"110","author":"RM Schiffman","year":"2003","unstructured":"Schiffman, R. M., Walt, J. G., Jacobsen, G., Doyle, J. J., Lebovics, G., & Sumner, W. (2003). Utility assessment among patients with dry eye disease. Ophthalmology, 110(7), 1412\u20131419.","journal-title":"Ophthalmology"},{"issue":"1","key":"1443_CR12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jval.2014.09.004","volume":"18","author":"Y Yang","year":"2015","unstructured":"Yang, Y., Rowen, D., Brazier, J., Tsuchiya, A., Young, T., & Longworth, L. (2015). An exploratory study to test the impact on three \u201cbolt-on\u201d items to the EQ-5D. Value in Health, 18(1), 52\u201360.","journal-title":"Value in Health"},{"issue":"8","key":"1443_CR13","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s11136-009-9524-9","volume":"18","author":"K Stevens","year":"2009","unstructured":"Stevens, K. (2009). Developing a descriptive system for a new preference-based measure of health-related quality of life for children. Quality of Life Research, 18(8), 1105\u20131113.","journal-title":"Quality of Life Research"},{"issue":"2","key":"1443_CR14","first-page":"1","volume":"16","author":"J Brazier","year":"2012","unstructured":"Brazier, J., Rowen, D., Mavranezouli, I., Tsuchiya, A., Young, T., Yang, Y., et al. (2012). Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome). Health Technology Assessment, 16(2), 1\u2013114.","journal-title":"Health Technology Assessment"},{"issue":"2","key":"1443_CR15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/hec.1580","volume":"19","author":"J Brazier","year":"2010","unstructured":"Brazier, J., & Tsuchiya, A. (2010). Preference-based condition-specific measures of health: What happens to cross programme comparability? Health Economics, 19(2), 125\u2013129.","journal-title":"Health Economics"},{"key":"1443_CR16","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3390\/jpm5040354","volume":"5","author":"JP Parisot","year":"2015","unstructured":"Parisot, J. P., Thorne, H., Fellowes, A., Doig, K., Lucas, M., McNeil, J. J., et al. (2015). Cancer 2015: A prospective, population-based cancer cohort\u2014phase 1: Feasibility of genomics-guided precision medicine in the clinic. Journal of Personalized Medicine, 5, 354\u2013369.","journal-title":"Journal of Personalized Medicine"},{"issue":"12","key":"1443_CR17","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.drudis.2015.10.009","volume":"20","author":"DM Thomas","year":"2015","unstructured":"Thomas, D. M., Fox, S., Lorgelly, P. K., Ashley, D., Richardson, G., Lipton, L., et al. (2015). Cancer 2015: A longitudinal whole-of-system study of genomic cancer medicine. Drug Discovery Today, 20(12), 1429\u20131432.","journal-title":"Drug Discovery Today"},{"issue":"8","key":"1443_CR18","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/bjc.2015.80","volume":"112","author":"S Wong","year":"2015","unstructured":"Wong, S., Fellowes, A., Doig, K., Ellul, J., Bosma, T., Irwin, D., et al. (2015). Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patients. British Journal of Cancer, 112(8), 1411\u20131420.","journal-title":"British Journal of Cancer"},{"issue":"6","key":"1443_CR19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF00422217","volume":"2","author":"DF Cella","year":"1993","unstructured":"Cella, D. F., Wiklund, I., Shumaker, S. A., & Aaronson, N. K. (1993). Integrating health-related quality of life into cross-national clinical trials. Quality of Life Research, 2(6), 433\u2013440.","journal-title":"Quality of Life Research"},{"issue":"5","key":"1443_CR20","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jval.2011.01.004","volume":"14","author":"D Rowen","year":"2011","unstructured":"Rowen, D., Brazier, J., Young, T., Gaugris, S., Craig, B. M., King, M. T., et al. (2011). Deriving a preference-based measure for cancer using the EORTC QLQ-C30. Value in Health, 14(5), 721\u2013731.","journal-title":"Value in Health"},{"issue":"1","key":"1443_CR21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","volume":"37","author":"R Brooks","year":"1996","unstructured":"Brooks, R. (1996). EuroQol: The current state of play. Health Policy, 37(1), 53\u201372.","journal-title":"Health Policy"},{"issue":"6","key":"1443_CR22","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hec.2953","volume":"23","author":"R Viney","year":"2014","unstructured":"Viney, R., Norman, R., Brazier, J., Cronin, P., King, M. T., Ratcliffe, J., et al. (2014). An Australian discrete choice experiment to value EQ-5D health states. Health Economics, 23(6), 729\u2013742.","journal-title":"Health Economics"},{"issue":"11","key":"1443_CR23","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","volume":"35","author":"P Dolan","year":"1997","unstructured":"Dolan, P. (1997). Modeling valuations for EuroQol health states. Medical Care, 35(11), 1095\u20131108.","journal-title":"Medical Care"},{"issue":"1","key":"1443_CR24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/(SICI)1099-1050(199902)8:1<41::AID-HEC395>3.0.CO;2-#","volume":"8","author":"J Brazier","year":"1999","unstructured":"Brazier, J., & Deverill, M. (1999). A checklist for judging preference-based measures of health related quality of life: Learning from psychometrics. Health Economics, 8(1), 41\u201351.","journal-title":"Health Economics"},{"key":"1443_CR25","unstructured":"Cohen, J. (1977). Statistical power analysis for the behavioral sciences (revised ed.): New York: Academic Press."},{"issue":"1","key":"1443_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7525-11-110","volume":"11","author":"M Obradovic","year":"2013","unstructured":"Obradovic, M., Lal, A., & Liedgens, H. (2013). Validity and responsiveness of EuroQol-5 dimension (EQ-5D) versus Short Form-6 dimension (SF-6D) questionnaire in chronic pain. Health and quality of life outcomes, 11(1), 1.","journal-title":"Health and quality of life outcomes"},{"issue":"6","key":"1443_CR27","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s11136-010-9649-x","volume":"19","author":"U Ravens-Sieberer","year":"2010","unstructured":"Ravens-Sieberer, U., Wille, N., Badia, X., Bonsel, G., Burstr\u00f6m, K., Cavrini, G., et al. (2010). Feasibility, reliability, and validity of the EQ-5D-Y: Results from a multinational study. Quality of Life Research, 19(6), 887\u2013897.","journal-title":"Quality of Life Research"},{"issue":"8476","key":"1443_CR28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"327","author":"MJ Bland","year":"1986","unstructured":"Bland, M. J., & Altman, D. G. (1986). Statistical methods for assessing agreement between two methods of clinical measurement. The Lancet, 327(8476), 307\u2013310.","journal-title":"The Lancet"},{"key":"1443_CR29","unstructured":"Rosner, B. A. (2011). The intraclass correlation coefficient. In B. A. Rosner (Ed.), Fundamentals of biostatistics. Pacific Grove."},{"issue":"4","key":"1443_CR30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1037\/1040-3590.6.4.284","volume":"6","author":"DV Cicchetti","year":"1994","unstructured":"Cicchetti, D. V. (1994). Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychological Assessment, 6(4), 284.","journal-title":"Psychological Assessment"},{"issue":"5","key":"1443_CR31","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40(5), 373\u2013383.","journal-title":"Journal of Chronic Diseases"},{"issue":"6","key":"1443_CR32","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken, M. M., Creech, R. H., Tormey, D. C., Horton, J., Davis, T. E., McFadden, E. T., et al. (1982). Toxicity and response criteria of the Eastern Cooperative Oncology Group. American Journal of Clinical Oncology, 5(6), 649\u2013656.","journal-title":"American Journal of Clinical Oncology"},{"issue":"1","key":"1443_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hec.667","volume":"11","author":"J Dowie","year":"2002","unstructured":"Dowie, J. (2002). Decision validity should determine whether a generic or condition-specific HRQOL measure is used in health care decisions. Health Economics, 11(1), 1\u20138.","journal-title":"Health Economics"},{"issue":"1","key":"1443_CR34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/hec.669","volume":"11","author":"J Brazier","year":"2002","unstructured":"Brazier, J., & Fitzpatrick, R. (2002). Measures of health-related quality of life in an imperfect world: A comment on Dowie. Health Economics, 11(1), 17\u201319. Discussion 21\u201312.","journal-title":"Health Economics"},{"issue":"1","key":"1443_CR35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1524-4733.2008.00413.x","volume":"12","author":"Y Yang","year":"2009","unstructured":"Yang, Y., Brazier, J., Tsuchiya, A., & Coyne, K. (2009). Estimating a preference-based single index from the overactive bladder questionnaire. Value in Health, 12(1), 159\u2013166.","journal-title":"Value in Health"},{"issue":"13","key":"1443_CR36","first-page":"3","volume":"3","author":"JE Brazier","year":"2005","unstructured":"Brazier, J. E., Roberts, J., Platts, M., & Zoellner, Y. F. (2005). Estimating a preference-based index for a menopause specific health quality of life questionnaire. Health and Quality of Life Outcomes, 3(13), 3\u201313.","journal-title":"Health and Quality of Life Outcomes"},{"issue":"2","key":"1443_CR37","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/0272989X10379646","volume":"31","author":"Y Yang","year":"2011","unstructured":"Yang, Y., Brazier, J. E., Tsuchiya, A., & Young, T. A. (2011). Estimating a preference-based index for a 5-dimensional health state classification for asthma derived from the asthma quality of life questionnaire. Medical Decision Making, 31(2), 281\u2013291.","journal-title":"Medical Decision Making"},{"issue":"8","key":"1443_CR38","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jval.2015.07.002","volume":"18","author":"E Goodwin","year":"2015","unstructured":"Goodwin, E., & Green, C. (2015). A quality-adjusted life-year measure for multiple sclerosis: Developing a patient-reported health state classification system for a multiple sclerosis-specific preference-based measure. Value in Health, 18(8), 1016\u20131024.","journal-title":"Value in Health"},{"issue":"2","key":"1443_CR39","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jval.2011.10.016","volume":"15","author":"D Rowen","year":"2012","unstructured":"Rowen, D., Mulhern, B., Banerjee, S., van Hout, B., Young, T. A., Knapp, M., et al. (2012). Estimating preference-based single index measures for dementia using DEMQOL and DEMQOL-Proxy. Value in Health, 15(2), 346\u2013356.","journal-title":"Value in Health"},{"issue":"8","key":"1443_CR40","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jval.2012.08.2201","volume":"15","author":"D Rowen","year":"2012","unstructured":"Rowen, D., Young, T., Brazier, J., & Gaugris, S. (2012). Comparison of generic, condition-specific, and mapped health state utility values for multiple myeloma cancer. Value in Health, 15(8), 1059\u20131068.","journal-title":"Value in Health"},{"issue":"1","key":"1443_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12955-014-0140-1","volume":"12","author":"AJ Hatswell","year":"2014","unstructured":"Hatswell, A. J., Pennington, B., Pericleous, L., Rowen, D., Lebmeier, M., & Lee, D. (2014). Patient-reported utilities in advanced or metastatic melanoma, including analysis of utilities by time to death. Health and Quality of Life Outcomes, 12(1), 1.","journal-title":"Health and Quality of Life Outcomes"},{"issue":"8","key":"1443_CR42","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jval.2015.08.012","volume":"18","author":"AJ Lloyd","year":"2015","unstructured":"Lloyd, A. J., Kerr, C., Penton, J., & Knerer, G. (2015). Health-related quality of life and health utilities in metastatic castrate-resistant prostate cancer: A survey capturing experiences from a diverse sample of UK patients. Value in Health, 18(8), 1152\u20131157.","journal-title":"Value in Health"},{"issue":"10","key":"1443_CR43","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10), 1727\u20131736.","journal-title":"Quality of Life Research"},{"key":"1443_CR44","volume-title":"An EQ-5D-5L value set for England","author":"N Devlin","year":"2015","unstructured":"Devlin, N., Shah, K., Feng, Y., Mulhern, B., & Van Hout, B. (2015). An EQ-5D-5L value set for England. London: Office of Health Economics Research Paper."},{"key":"1443_CR45","doi-asserted-by":"crossref","unstructured":"Versteegh, M. M., Vermeulen, K. M., Evers, S. M., de Wit, G. A., Prenger, R., & Stolk, E. A. (2016). Dutch tariff for the five-level version of EQ-5D. Value in Health.","DOI":"10.1016\/j.jval.2016.01.003"},{"issue":"1","key":"1443_CR46","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MLR.0000000000000447","volume":"54","author":"Xie, F., Pullenayegum, E., Gaebel, K., Bansback, N., Bryan, S., Ohinmaa, A., Poissant, L., Johnson, J. A., & Group, o. b. o. t. C. E.-D.-L. V. S","year":"2016","unstructured":"Xie, F., Pullenayegum, E., Gaebel, K., Bansback, N., Bryan, S., Ohinmaa, A., Poissant, L., Johnson, J. A., & Group, o. b. o. t. C. E.-D.-L. V. S. (2016). A time trade-off-derived value set of the EQ-5D-5L for Canada. Medical Care, 54(1), 98\u2013105.","journal-title":"Medical Care"},{"key":"1443_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7525-11-81","volume":"11","author":"N Turner","year":"2013","unstructured":"Turner, N., Campbell, J., Peters, T. J., Wiles, N., & Hollinghurst, S. (2013). A comparison of four different approaches to measuring health utility in depressed patients. Health and Quality of Life Outcomes, 11, 1.","journal-title":"Health and Quality of Life Outcomes"},{"issue":"1","key":"1443_CR48","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1477-7525-4-20","volume":"4","author":"HF Stel van","year":"2006","unstructured":"van Stel, H. F., & Buskens, E. (2006). Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease. Health and Quality of Life Outcomes, 4(1), 20.","journal-title":"Health and Quality of Life Outcomes"},{"key":"1443_CR49","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2147\/PROM.S68776","volume":"5","author":"DS Costa","year":"2014","unstructured":"Costa, D. S., Aaronson, N. K., Fayers, P. M., Grimison, P. S., Janda, M., Pallant, J. F., et al. (2014). Deriving a preference-based utility measure for cancer patients from the European organisation for the research and treatment of cancer\u2019s quality of life questionnaire C30: A confirmatory versus exploratory approach. Patient Related Outcome Measures, 5, 119.","journal-title":"Patient Related Outcome Measures"},{"issue":"3","key":"1443_CR50","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s11136-015-1217-y","volume":"25","author":"M King","year":"2016","unstructured":"King, M., Costa, D., Aaronson, N., Brazier, J., Cella, D., Fayers, P., et al. (2016). QLU-C10D: A health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30. Quality of Life Research, 25(3), 625\u2013636.","journal-title":"Quality of Life Research"},{"issue":"3","key":"1443_CR51","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s11136-015-1115-3","volume":"22","author":"R Norman","year":"2016","unstructured":"Norman, R., Viney, R., Aaronson, N., Brazier, J., Cella, D., Costa, D., et al. (2016). Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format. Quality of Life Research, 22(3), 637\u2013649.","journal-title":"Quality of Life Research"},{"issue":"Suppl 1","key":"1443_CR52","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1186\/2052-3211-8-S1-K1","volume":"8","author":"SR Hill","year":"2015","unstructured":"Hill, S. R. (2015). Affordable innovation: Future directions in pharmaceutical policy. Journal of Pharmaceutical Policy and Practice, 8(Suppl 1), K1.","journal-title":"Journal of Pharmaceutical Policy and Practice"},{"issue":"1","key":"1443_CR53","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1257\/jep.29.1.139","volume":"29","author":"DH Howard","year":"2015","unstructured":"Howard, D. H., Bach, P. B., Berndt, E. R., & Conti, R. M. (2015). Pricing in the market for anticancer drugs. Journal of Economic Perspectives, 29(1), 139\u2013162.","journal-title":"Journal of Economic Perspectives"},{"issue":"8","key":"1443_CR54","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2165\/11588250-000000000-00000","volume":"29","author":"M Garau","year":"2011","unstructured":"Garau, M., Shah, K. K., Mason, A. R., Wang, Q., Towse, A., & Drummond, M. F. (2011). Using QALYs in cancer. Pharmacoeconomics, 29(8), 673\u2013685.","journal-title":"Pharmacoeconomics"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-016-1443-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11136-016-1443-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-016-1443-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T23:12:57Z","timestamp":1498345977000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11136-016-1443-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,9]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["1443"],"URL":"https:\/\/doi.org\/10.1007\/s11136-016-1443-y","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,9]]}}}